Skip to content

Clinical trials

Schizophrenia trials in Colombia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Colombia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20083
20091
20103
20114
20122
20134
20193
20212
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.6
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Alkermes, Inc.2
Boehringer Ingelheim2
FORUM Pharmaceuticals Inc2
Forest Laboratories2
Hoffmann-La Roche2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Bristol-Myers Squibb1
Gedeon Richter Plc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia29
Bipolar Disorder3
Cognition Disorders2
Mental Disorders2
Autism Spectrum Disorder1
Autistic Disorder1

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.